|
Dr. Dreismann is former president and CEO of Roche Molecular Diagnostics (RMD), a pioneer in PCR-based (polymerase chain reaction) molecular diagnostic tests and division of F. Hoffmann-La Roche Ltd. During his tenure as CEO of RMD, he oversaw significant expansion of the company’s product portfolio, and the company’s sales doubled under his leadership. Previously within Roche Diagnostics, he held several other executive positions in global business development, public relations, and R&D for microbiology and infectious disease products. In addition, his experience leading the integration following the merger of Boehringer Mannheim and Roche Diagnostics in 1998 brings significant value to Magellan. He currently serves on the boards of several biotech and diagnostic companies. Dr. Dreismann received his master’s in biology from Westfalische Wilheims University in Munster, Germany, and his PhD in microbiology/molecular biology from the University of Munster. |
